Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
| ▸ | PLA2G6 | O60733 | 2/20 | 0.35 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22610064 | 0.92 | ALDH1A1 (0.51) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL22632177 | 0.92 | TP53 (0.51) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL21623608 | 0.85 | PPARA (0.48) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL21623607 | 0.85 | PPARA (0.44) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL8469317 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL4648034 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL8507559 | 0.81 | TP53 (0.64) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL38657149 | 0.81 | TP53 (0.64) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL24117325 | 0.80 | ENPP2 (0.35) | PPARAPPARGSPHK2SPHK1CNR1 | |
| SCHEMBL13251414 | 0.79 | ALDH1A1 (0.68) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492317-B2 | Synthesis of bio-based polyols from epoxidized cardanol and epoxidized triglyceride by using thiol-containing reagents | THE UNIVERSITY OF AKRON (US) | 2022-11-08 | — | — | US | disclosed |
| US-11365324-B2 | Active-energy-ray curable offset printing ink composition, and method for manufacturing printed matter and method for enhancing gloss of printed matter using the same | SAKATA INX CORPORATION (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20220169871-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING PRINTED MATTER IN WHICH SAME IS USED | SAKATA INX CORPORATION (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20220162453-A1 | ACTIVE ENERGY RAY-CURABLE VARNISH COMPOSITION, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING PRINTED MATTER USING SAME | SAKATA INX CORPORATION (JP) | 2022-05-26 | — | — | US | disclosed |
| EP-3950751-A1 | ACTIVE ENERGY RAY-CURABLE VARNISH COMPOSITION, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING PRINTED MATTER USING SAME | Sakata INX Corporation (JP) | 2022-02-09 | — | — | EP | disclosed |
| EP-3943311-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING PRINTED MATTER IN WHICH SAME IS USED | Sakata INX Corporation (JP) | 2022-01-26 | — | — | EP | disclosed |
| EP-3822324-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION FOR OFFSET PRINTING, AND METHOD FOR PRODUCING PRINTED MATTER USING SAME | Sakata INX Corporation (JP) | 2021-05-19 | — | — | EP | disclosed |
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | CARDOLITE CORPORATION (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | THE UNIVERSITY OF AKRON | 2020-11-05 | — | — | US | disclosed |
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | THE UNIVERSITY OF AKRON | 2020-11-05 | — | — | US | disclosed |
| EP-3722380-A1 | ACTIVE-ENERGY-RAY CURABLE OFFSET PRINTING INK COMPOSITION, AND METHOD FOR MANUFACTURING PRINTED MATTER AND METHOD FOR ENHANCING GLOSS OF PRINTED MATTER USING SAME | Sakata INX Corporation (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-20200317938-A1 | ACTIVE-ENERGY-RAY CURABLE OFFSET PRINTING INK COMPOSITION, AND METHOD FOR MANUFACTURING PRINTED MATTER AND METHOD FOR ENHANCING GLOSS OF PRINTED MATTER USING THE SAME | SAKATA INX CORPORATION (JP) | 2020-10-08 | — | — | US | disclosed |
| WO-2020202918-A1 | ACTIVE ENERGY RAY-CURABLE VARNISH COMPOSITION, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING PRINTED MATTER USING SAME | サカタインクス株式会社 | 2020-10-08 | — | — | WO | disclosed |
| WO-2020195469-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING PRINTED MATTER IN WHICH SAME IS USED | サカタインクス株式会社 | 2020-10-01 | — | — | WO | disclosed |
| WO-2020012965-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION FOR OFFSET PRINTING, AND METHOD FOR PRODUCING PRINTED MATTER USING SAME | サカタインクス株式会社 | 2020-01-16 | — | — | WO | disclosed |
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | CARDOLITE CORPORATION | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | GSTO1, FDFT1, DGAT2 | ALDH1A1 632/4885TP53 2635/4885CYP3A4 502/4885 |
| US-11492317-B2 | Synthesis of bio-based polyols from epoxidized cardanol and epoxidized triglyceride by using thiol-containing reagents | GSTO1, FDFT1, DGAT2 | ALDH1A1 632/4885TP53 2635/4885CYP3A4 502/4885 |
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | NANS, SGMS1, FUT6 | ALDH1A1 2958/4885TP53 273/4885CYP3A4 2815/4885 |
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | NANS, SGMS1, FUT6 | ALDH1A1 2958/4885TP53 273/4885CYP3A4 2815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.